Table 6.
Resistance | Mutation patterns | Treatment adaptation |
LAM | M204V/I + L180M M204I M204V + L180M + V173L M204I + L180I Q215S + M204I/V + M204V I169T + V173L + L180M + M204V A181T T184S + M204I/V + L180M M204S + L180M | Switch to TDF or Switch to ETV + ADV combination therapy or Add ADV if TDF or ETV unavailable |
ADV | A181V/T N236T A181V/T + N236T | Switch to TDF and add ETV |
ADV + LAM | A181V/T + N236T L80V/I | Switch to TDF and add ETV |
TBV | M204I/V ± L180M L80I/V ± L180M A181T/V | Switch to or add TDF |
ETV | L180M + M204V/I ± I169T ± M250V L180M + M204V/I ± T184G ± S202I/G | Switch to or add TDF |
TDF | No known mutations | N/A |
Common mutation patterns, and rescue therapies suggested by the American Association for the Society of Liver Disease, Asian Pacific Association for the Study of Liver; European Association for the Study of Liver and National Institute for Health and Care Excellence. LAM: Lamivudine; ETV: Entecavir; ADV: Adefovir; TBV: Telbivudine; TDF: Tenofovir disoproxil fumarate.